Plaque characteristics and biomarkers predicting regression and progression of carotid atherosclerosis.


Journal

Cell reports. Medicine
ISSN: 2666-3791
Titre abrégé: Cell Rep Med
Pays: United States
ID NLM: 101766894

Informations de publication

Date de publication:
19 07 2022
Historique:
received: 23 08 2021
revised: 10 04 2022
accepted: 10 06 2022
entrez: 20 7 2022
pubmed: 21 7 2022
medline: 23 7 2022
Statut: ppublish

Résumé

The factors that influence the atherosclerotic disease process in high-risk individuals remain poorly understood. Here, we used a combination of vascular imaging, risk factor assessment, and biomarkers to identify factors associated with 3-year change in carotid disease severity in a cohort of high-risk subjects treated with preventive therapy (n = 865). The results show that changes in intima-media thickness (IMT) are most pronounced in the carotid bulb. Progression of bulb IMT demonstrates independent associations with baseline bulb IMT, the plaque gray scale median (GSM), and the plasma level of platelet-derived growth factor (PDGF) (standardized β-coefficients and 95% confidence interval [CI] -0.14 [-0.06 to -0.02] p = 0.001, 0.15 [0.02-0.07] p = 0.001, and 0.20 [0.03-0.07] p < 0.001, respectively). Plasma PDGF correlates with the plaque GSM (0.23 [0.15-0.29] p < 0.001). These observations provide insight into the atherosclerotic process in high-risk subjects by showing that progression primarily occurs in fibrotic plaques and is associated with increased levels of PDGF.

Identifiants

pubmed: 35858591
pii: S2666-3791(22)00212-9
doi: 10.1016/j.xcrm.2022.100676
pmc: PMC9381367
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100676

Subventions

Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Crown Copyright © 2022. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

JAMA. 2012 Aug 22;308(8):796-803
pubmed: 22910757
N Engl J Med. 2017 Apr 13;376(15):1407-1418
pubmed: 28402770
JACC Cardiovasc Imaging. 2014 Oct;7(10):1025-38
pubmed: 25051948
Eur Heart J. 2022 Feb 10;43(6):450-459
pubmed: 34849704
Stroke. 2004 Dec;35(12):2795-800
pubmed: 15514195
Nature. 2021 Apr;592(7855):524-533
pubmed: 33883728
Eur J Vasc Endovasc Surg. 2014 Aug;48(2):118-25
pubmed: 24947079
N Engl J Med. 2005 Apr 21;352(16):1685-95
pubmed: 15843671
Nat Rev Dis Primers. 2019 Aug 16;5(1):56
pubmed: 31420554
Circulation. 1998 Jan 6-13;97(1):34-40
pubmed: 9443429
EBioMedicine. 2017 Dec;26:187-197
pubmed: 29208468
Sci Transl Med. 2020 Dec 2;12(572):
pubmed: 33268513
Clin Physiol Funct Imaging. 2013 Nov;33(6):431-5
pubmed: 23701450
Circ Res. 2014 Jun 6;114(12):1867-79
pubmed: 24902971
Circulation. 1998 Sep 1;98(9):839-44
pubmed: 9738637
Circulation. 2001 Jul 3;104(1):68-73
pubmed: 11435340
Curr Opin Lipidol. 2004 Oct;15(5):575-82
pubmed: 15361794
Circ Res. 2014 Jun 6;114(12):1852-66
pubmed: 24902970
Circ Res. 2010 Apr 2;106(6):1174-7
pubmed: 20167929
Eur Heart J. 2015 Nov 14;36(43):2984-7
pubmed: 26206212
N Engl J Med. 2013 May 23;368(21):2004-13
pubmed: 23697515
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):222-8
pubmed: 25359857
Atherosclerosis. 2015 Apr;239(2):615-21
pubmed: 25746169
Nat Metab. 2020 Oct;2(10):1135-1148
pubmed: 33067605
N Engl J Med. 2010 Jun 10;362(23):2155-65
pubmed: 20558366
Cardiovasc Res. 1993 Jul;27(7):1184-90
pubmed: 8252576
J Intern Med. 2015 Sep;278(3):291-302
pubmed: 25752315
Circulation. 2001 Feb 20;103(7):926-33
pubmed: 11181465
Int J Mol Sci. 2015 May 12;16(5):10734-47
pubmed: 25984600
PLoS One. 2015 May 05;10(5):e0124769
pubmed: 25942424
Circulation. 2014 Jun 3;129(22):2269-76
pubmed: 24637558
J Am Heart Assoc. 2015 Feb 19;4(2):
pubmed: 25699995
Nat Rev Cardiol. 2016 Apr;13(4):210-20
pubmed: 26822720
Eur Heart J. 2017 Jun 1;38(21):1638-1644
pubmed: 28387815
PLoS One. 2018 Apr 12;13(4):e0191172
pubmed: 29649236
Diabetes Care. 2018 Oct;41(10):2212-2219
pubmed: 30061319
Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):1723-31
pubmed: 25953645
Stroke. 1999 Apr;30(4):841-50
pubmed: 10187889

Auteurs

Faisel Khan (F)

Division of Systems Medicine, University of Dundee, Dundee, UK.

Isabel Gonçalves (I)

Department of Clinical Sciences Malmö, Lund University, Lund, Sweden; Department of Cardiology, Skåne University Hospital, Malmö, Sweden.

Angela C Shore (AC)

Diabetes and Vascular Medicine, University of Exeter Medical School and NIHR Exeter Clinical Research Facility, Exeter, UK.

Andrea Natali (A)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Carlo Palombo (C)

Department of Surgical, Medical, Molecular, and Critical Area Pathology, University of Pisa, Pisa, Italy.

Helen M Colhoun (HM)

Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

Gerd Östling (G)

Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.

Francesco Casanova (F)

Diabetes and Vascular Medicine, University of Exeter Medical School and NIHR Exeter Clinical Research Facility, Exeter, UK.

Cecilia Kennbäck (C)

Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.

Kunihiko Aizawa (K)

Diabetes and Vascular Medicine, University of Exeter Medical School and NIHR Exeter Clinical Research Facility, Exeter, UK.

Margaretha Persson (M)

Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.

Kim M Gooding (KM)

Diabetes and Vascular Medicine, University of Exeter Medical School and NIHR Exeter Clinical Research Facility, Exeter, UK.

David Strain (D)

Diabetes and Vascular Medicine, University of Exeter Medical School and NIHR Exeter Clinical Research Facility, Exeter, UK.

Helen Looker (H)

Division of Systems Medicine, University of Dundee, Dundee, UK.

Fiona Dove (F)

Division of Systems Medicine, University of Dundee, Dundee, UK.

Jill Belch (J)

Division of Systems Medicine, University of Dundee, Dundee, UK.

Silvia Pinnola (S)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Elena Venturi (E)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Michaela Kozakova (M)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; Department of Surgical, Medical, Molecular, and Critical Area Pathology, University of Pisa, Pisa, Italy.

Jan Nilsson (J)

Department of Clinical Sciences Malmö, Lund University, Lund, Sweden. Electronic address: jan.nilsson@med.lu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH